UNITY Biotechnology (UBX) Misses Q3 EPS by 16c

UNITY Biotechnology (NASDAQ: UBX) reported Q3 EPS of ($1.05), $0.16 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on UNITY Biotechnology (UBX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Hyperscale Data signs $1.2B AI compute deal for Michigan campus
• Stifel Canada Starts BlackBerry (BB) at Buy